Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline

K Visvanathan, P Hurley, E Bantug, P Brown… - Journal of Clinical …, 2013 - ascopubs.org
Purpose To update the 2009 American Society of Clinical Oncology guideline on
pharmacologic interventions for breast cancer (BC) risk reduction. Methods A systematic …

Endocrine risk factors of endometrial cancer: polycystic ovary syndrome, oral contraceptives, infertility, tamoxifen

A Ignatov, O Ortmann - Cancers, 2020 - mdpi.com
Endometrial cancer is the most common gynecologic cancer and is predominantly
endocrine-related. The role of unopposed estrogen in the development of endometrial …

Breast cancer in young women

SA Narod - Nature reviews Clinical oncology, 2012 - nature.com
About one in 300 women will be diagnosed with breast cancer before the age of 40.
Advances in screening have not had an impact on mortality in women who are too young to …

Risk of endometrial polyps, hyperplasia, carcinoma, and uterine cancer after tamoxifen treatment in premenopausal women with breast cancer

KJ Ryu, MS Kim, JY Lee, S Nam, HG Jeong… - JAMA network …, 2022 - jamanetwork.com
Importance The association of tamoxifen use with the risk of uterine diseases, such as
endometrial cancer, in premenopausal women with breast cancer remains controversial …

Use of medications to reduce risk for primary breast cancer: a systematic review for the US Preventive Services Task Force

HD Nelson, MEB Smith, JC Griffin… - Annals of internal medicine, 2013 - acpjournals.org
Background: Medications to reduce risk for primary breast cancer are recommended for
women at increased risk; however, use is low. Purpose: To update evidence about the …

[HTML][HTML] Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer …

T Grantzau, L Mellemkjær, J Overgaard - Radiotherapy and Oncology, 2013 - Elsevier
BACKGROUND AND PURPOSE: To analyze the long-term risk of second primary solid non-
breast cancer in a national population-based cohort of 46,176 patients treated for early …

[PDF][PDF] Risk factors associated with endometrial pathology in premenopausal breast cancer patients treated with tamoxifen

M Lee, J Piao, MJ Jeon - Yonsei medical journal, 2020 - synapse.koreamed.org
Purpose: To evaluate factors associated with endometrial pathology during tamoxifen use in
premenopausal breast cancer (BC) patients. Materials and Methods: We reviewed the …

The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study

Y Segev, J Iqbal, J Lubinski, J Gronwald, HT Lynch… - Gynecologic …, 2013 - Elsevier
OBJECTIVE: To evaluate the risk of endometrial cancer in women who carry a mutation in
the BRCA1 or the BRCA2 gene. METHODS: We followed 4456 women with a BRCA1 or a …

Precision prevention and early detection of cancer: fundamental principles

TR Rebbeck, K Burns-White, AT Chan, K Emmons… - Cancer discovery, 2018 - AACR
Prevention and early detection is critical for reducing the population cancer burden. Two
approaches have been used: Population approaches change social norms (eg, smoking …

[HTML][HTML] BRCA1 and BRCA2 mutations and breast cancer

SA Narod, L Salmena - Discovery medicine, 2011 - discoverymedicine.com
Genetic testing for BRCA mutations is expanding in clinical oncology centers worldwide.
Testing may help target unaffected high-risk women for prevention and/or close surveillance …